WHO ICTRP trial
Effects of DDAVP (1-deamino-8-D arginine vasopressin) infusion on parameters of…
NL-OMON39451 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON39451 |
|---|---|
| Public title | Effects of DDAVP (1-deamino-8-D arginine vasopressin) infusion on parameters of hemostasis in patients with liver cirrhosis |
| Scientific title | Effects of DDAVP (1-deamino-8-D arginine vasopressin) infusion on parameters of hemostasis in patients with liver cirrhosis - DDAVP in cirrhosis |
| Primary sponsor | Universitair Medisch Centrum Groningen |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Netherlands |
| Conditions | Liver failure liver fibrosis;10064477;10019654;10025309;Liver failure;liver fibrosis |
| Interventions | Patients will be administered a single dose of DDAVP (0.3 µg/kg, intravenously) Blood samples (10 ml, into trisodiumcitrate) will be taken just before infusion, and 1, 3, 6, and 24 hours after infusion. ;DDAVP;Hemostasis;Liver… |
| Registration date | Jun 24, 2013 |
| Target size | 10 |
| Secondary IDs | 2010-021827-28;NL40025.042.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: